PUBLISHER: The Business Research Company | PRODUCT CODE: 1666383
PUBLISHER: The Business Research Company | PRODUCT CODE: 1666383
Anastomosis devices are instruments, either disposable or reusable, designed to create inverted or everted tissue closures using two or more rows of B-shaped stainless steel, titanium, or occasionally absorbable staples. Their purpose is to remove diseased tissues from the body while preventing the leakage of bodily fluids.
The primary categories of anastomosis devices include surgical staplers, surgical sutures, surgical sealants and adhesives, and automated suturing. Surgical staplers are tools employed to close significant surgical wounds or incisions on the scalp or skin, applying staples to various tissues within the body during surgery. They find application in cardiovascular and thoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, and other medical procedures. These devices are utilized in various healthcare settings such as hospitals and ambulatory surgery centers, among others.
The anastomosis devices market research report is one of a series of new reports from The Business Research Company that provides anastomosis devices market statistics, including the anastomosis devices industry global market size, regional shares, competitors with an anastomosis devices market share, detailed anastomosis devices market segments, market trends, and opportunities, and any further data you may need to thrive in the anastomosis devices industry. This anastomosis devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The anastomosis devices market size has grown strongly in recent years. It will grow from$3.66 billion in 2024 to $3.9 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increasing surgical procedures, a growing aging population, the prevalence of chronic diseases, and improvements in healthcare infrastructure, awareness, and education
The anastomosis devices market size is expected to see strong growth in the next few years. It will grow to $5.21 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to rising global healthcare expenditure, expansion of minimally invasive surgeries, advancements in anastomosis device designs, focus on patient outcomes, and global increase in chronic diseases. Major trends in the forecast period include a focus on patient outcomes and quality of life, the development of anastomosis sealants, the prevalence of colorectal diseases, the global aging population, collaborations, and partnerships.
The anticipated increase in surgical procedures is expected to drive the growth of the anastomosis device market in the future. Surgical procedures involve any medical intervention that requires making an incision on a patient's body. Anastomosis devices are primarily utilized in surgeries to connect two segments of the body, such as blood vessels or intestines. For example, a report from The Aesthetic Society, a U.S.-based organization focused on plastic surgery and cosmetic medicine, indicated that Americans spent over $11.8 billion on aesthetic procedures in August 2023, reflecting a 2% increase from the previous year. Consequently, the rise in surgical procedures will fuel the expansion of the anastomosis device market.
The increasing aging population is anticipated to drive the growth of the anastomosis device market in the coming years. An aging population refers to a demographic trend marked by a growing percentage of elderly individuals in society over time. Anastomosis devices are essential in healthcare for the elderly, as they address various medical issues that become more common with advancing age. For example, the Population Reference Bureau, a U.S.-based nonprofit organization, reported in January 2024 that the number of Americans aged 65 and older is projected to rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, the proportion of this age group within the total population is expected to grow from 17% to 23% during the same timeframe. Therefore, the increasing aging population is driving demand for the anastomosis device market.
The introduction of technologically advanced products is a significant trend in the anastomosis device market. Leading companies in this sector are focusing on innovation and launching cutting-edge products and technologies to maintain their competitive edge. For example, in May 2024, Ethicon, a U.S.-based medical device company, introduced the ECHELON LINEAR Cutter, a revolutionary surgical stapler designed to improve surgical outcomes by drastically reducing the risk of leaks at the staple line. This innovative device is said to produce 47% fewer leaks compared to conventional staplers, helping to reduce potential complications during and after surgery. The primary goal of the ECHELON Linear Cutter is to lower the incidence of leaks at the staple line, which is essential for ensuring the integrity of tissue closures. Leaks can result in serious complications, including infections and prolonged recovery times.
Leading companies in the anastomosis device market are also directing their efforts toward the development of advanced solutions, such as the suture anchor system. This medical device is employed in orthopaedic and sports medicine procedures to securely attach soft tissues (such as tendons or ligaments) to bone. For example, in December 2022, Stryker Corporation, a US-based medical device manufacturing company, launched 'Citrefix,' a suture anchor system designed with innovative bioresorbable material for foot and ankle surgical procedures. Citrefix, a disposable suture system made from Citregen (an elastomeric material derived from a citrate polymer), is engineered to mimic bone chemistry, ensuring controlled resorption without inducing chronic inflammation.
In March 2024, Advanced Medical Solutions PLC, a medical technology company based in the UK, acquired Peters Surgical for an undisclosed sum. This acquisition is intended to help Advanced Medical Solutions PLC enhance its presence in the operating room, broaden its product portfolio and sales, improve direct selling capabilities, and strengthen its global industrial footprint. Peters Surgical, located in France, specializes in medical technology, particularly in surgical closure devices.
Major companies operating in the anastomosis devices market include Medtronic plc, Synvisc Micro Companies Alliance Inc., B. Braun Melsungen AG, Novare Surgical Systems Inc., Dextera Surgical Inc., Intuitive Surgical Inc., Boston Scientific Corp., Artivion Inc., Johnson & Johnson Services Inc., Rochling Group, Bluesail Surgical, Vascular Graft Solutions Ltd., Baxter International Inc., LivaNova plc, Getinge AB, Meril Life Sciences Pvt. Ltd., Becton, Dickinson and Company, Terumo Corporation, Teleflex Incorporated, Scanlan International Inc., Microline Surgical Inc., Grena Ltd., CryoLife Inc., Cardica Inc., Stryker Corporation, LifeNet Health Inc., Jotec GmbH, JenaValve Technology Inc., Innovia Medical, Genesee BioMedical Inc., EndoEvolution LLC, Edwards Lifesciences Corporation, ConMed Corporation, Cardialen Inc.
North America was the largest region in the anastomosis devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global anastomosis devices market report during the forecast period. The regions covered in the anastomosis devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the anastomosis devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The anastomosis devices market consists of sales of cannula, robotics, and incision devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Anastomosis Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on anastomosis devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for anastomosis devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anastomosis devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.